Global Embolic Protection Devices Market Overview
Introduction:
During percutaneous cardiac operations, embolic safety devices (EPDs) are most commonly used to minimise the number of complications caused by debris being released into the bloodstream and creating blockages in smaller vessels. These devices are part of the safest, most evidence-based treatment for preventing periprocedural myocardial infarction and other significant cardiovascular events. Distal occlusion aspiration devices, distal filters, and proximal occlusion aspiration devices are the three types of EPDs based on their mechanism of action. A balloon catheter is used in distal occlusion devices to momentarily block blood flow in a vessel while the operation is performed. A catheter is a thin tube made of medical-grade materials and inserted into the body to treat diseases or perform surgery. The global Embolic protection devices market accounted for US$ 436.2 million in 2020 and is estimated to be US$ 1020.3 million by 2030 and is anticipated to register a CAGR of 8.9%.
Impact of Covid-19 pandemic on market
Medical devices are in high demand to help with the treatment of COVID-19 patients. Life-support machines, oxygen generators, atomizers, and monitors are some of the respiratory devices that can be used to help patients who are suffering from viral infections. With the outbreak of the viral infection and an increase in the number of COVID-19 cases around the world, demand for medical supplies continues to rise among healthcare professionals and the general public for precautionary measures. As a result of the risk of infection spreading, surgical procedures have been reduced, and the demand for embolic safety devices is currently growing at a slower pace.
Global Embolic Protection Devices Market Dynamics
Rising initiatives by government bodies
Government agencies, non-governmental organisations (NGOs), and educational institutions from all over the world are running awareness campaigns about cardiovascular and neurovascular disorders, as well as potential treatments.. Recent advances in visual amplification have made it easier for healthcare providers to perceive clinical results. The high cost of surgeries in low-income and developing countries, is one of the major challenges. In addition to cost-effectiveness, the embolic defence devices industry's development is expected to be hampered in the near future by an increase in product failures and recalls as a result of the government's strict guidelines for the implication of surgeries.
Growth in business operations by emerging and small sized players
The need for surgical treatments will increase as the incidence of cardiovascular diseases rises. During the forecast period, the demand for embolic safety devices will be driven by the rising prevalence of chronic diseases in both developed and developing countries. As a result, rising adoption of embolic safety devices to catch and remove debris that may be extricated during procedures would spur industry growth in the coming years. Another positive effect rendering driver for business development would be technological innovation in embolic defence systems. The industry's focus on the production of creative and affordable devices will help in market expansion.
Global Embolic Protection Devices Market Segmentation
Source: Prophecy Market Insights
The global Embolic protection Devices market is segmented based on product, material, application, end-use and region.
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
On the basis of product, the global Embolic protection devices market is segmented into proximal occlusion devices, distal occlusion devices and distal filter devices. Based on site of material, the target market is segmented into polyurethane and Nitinol. On the basis of application, the target market is segmented into cardiovascular diseases, Neurovascular disease and peripheral disease. On the basis of end-use, the target market is segmented into hospitals and ambulatory surgical centers.
Regional Insights:
On region the global Embolic protection devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted the largest share of the market, followed by Europe. Asia Pacific is expected to be profitable in the coming years as a result of public and private sector investments, enhanced healthcare facilities, and rising disposable income.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Product- proximal occlusion devices, distal occlusion devices and distal filters devices By Material– polyurethane and Nitinol By Application– cardiovascular diseases, Neurovascular disease and peripheral disease By End-use- hospitals and ambulatory surgical centers |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global Embolic protection devices market report based on product, material, application, end-use and region.
Global Embolic protection Devices Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Embolic Protection Devices Market Key Players
The key players operating in the global Embolic protection devices market includes Abbott Laboratories, Claret Medical Inc, Boston Scientific Corporation, Contego Medical LLC, Medtronic Inc , L. Gore & Associates Inc, Ltd, Cardinal Health Inc , AngioSlide, Allium Medical Solutions Ltd, Silk Road Medical Inc, AngioSlide, Transverse Medical, Innovative Cardiovascular Solutions, Edward Lifesciences and LEPU MEDICAL TECHNOLOGY .
Global Embolic Protection Devices Market Company Profile
- Abbott laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Boston Scientific Corporation
- Claret medical Inc.
- Medtronic Inc.
- Contego medical LLC
- Cardinal health Inc.
- L. Gore and Associates Inc. Ltd
- Allium medical Solutions Ltd.
- Angioslide
- Silk road medical Inc.
- Innovative cardiovascular Solutions
- Transverse medical
- Edward Lifesciences
- LEPU Medical Technology
“*” marked represents similar segmentation in other categories in the respective section
Global Embolic Protection Devices Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Embolic protection Devices Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product
- Market Snippet, By Material
- Market Snippet, By Application
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Embolic protection devices Market, By Product, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Proximal occlusion devices
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Distal occlusion devices
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Distal filter devices
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Embolic protection devices Market, By Material, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Polyurethane
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Nitinol
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Embolic protection devices Market, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Cardiovascular diseases
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Neurovascular disease
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Peripheral disease
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Embolic protection devices Market, By End-User, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Ambulatory surgical centers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Embolic protection devices Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Abbott laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Boston Scientific Corporation
- Claret medical Inc.
- Medtronic Inc.
- Contego medical LLC
- Cardinal health Inc.
- L. Gore and Associates Inc. Ltd
- Allium medical Solutions Ltd.
- Angioslide
- Silk road medical Inc.
- Innovative cardiovascular Solutions
- Transverse medical
- Edward Lifesciences
- LEPU Medical Technology
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
The Embolic protection devices market accounted for US$ 436.2 million in 2020 and is estimated to be US$ 1020.3 million by 2030 and is anticipated to register a CAGR of 8.9%.
The Embolic protection Devices Market is segmented based on the product, material, end-use and region.
Emerging trends include the development of next-generation embolic protection devices, the increasing use of embolic protection in various cardiovascular interventions, and the expansion of applications in both coronary and peripheral vascular procedures, presenting significant opportunities in the global Embolic Protection Devices Market.
Factors driving the market include the rising incidence of cardiovascular diseases, advancements in embolic protection device technologies, the demand for minimally invasive vascular interventions, and the growing awareness of the importance of preventing embolic complications during procedures.
The report covers regions worldwide. North America is expected to dominate the Embolic Protection Devices Market, driven by a well-established healthcare infrastructure, a high prevalence of cardiovascular diseases, and significant research and development activities in the region. Other influential regions include Europe and Asia-Pacific.
The key players operating in the global Embolic protection devices market includes Abbott Laboratories, Claret Medical Inc, Boston Scientific Corporation, Contego Medical LLC, Medtronic Inc , L. Gore & Associates Inc, Ltd, Cardinal Health Inc , AngioSlide, Allium Medical Solutions Ltd, Silk Road Medical Inc, AngioSlide, Transverse Medical, Innovative Cardiovascular Solutions, Edward Lifesciences and LEPU MEDICAL TECHNOLOGY .